应用于随机肽文库的靶标辅助迭代筛选揭示了CIN85/SETA/RukSH3结构域共有的新型和非典型识别共识,PX(P/A)XXR。通过诱变和体外结合实验证实,新的共识允许在已知的CIN85相互作用剂中准确定位CIN85SH3结合位点,c-Cbl,BLNK,Cbl-b,AIP1/Alix,SB1和CD2蛋白,以及蛋白质数据库中CIN85新相互作用伴侣的预测。Synaptojanin1,PAK2,ZO-2和TAFII70,包含CIN85SH3识别共识位点,在谷胱甘肽S-转移酶下拉实验中,通过CIN85SH3结构域从小鼠脑裂解物中选择性沉淀。FarWestern印迹证实了突触素1和PAK2与CIN85SH3结构域的直接相互作用。
Target-assisted iterative screening applied to random peptide libraries unveiled a novel and atypical recognition
consensus shared by CIN85/SETA/Ruk SH3 domains, PX(P/A)XXR. Confirmed by mutagenesis and in vitro binding experiments, the novel
consensus allowed for the accurate mapping of CIN85 SH3 binding sites within known CIN85 interactors, c-Cbl, BLNK, Cbl-b, AIP1/Alix, SB1, and CD2 proteins, as well as the prediction of CIN85 novel-interacting partners in protein databases. Synaptojanin 1, PAK2, ZO-2, and TAFII70, which contain CIN85 SH3 recognition
consensus sites, were selectively precipitated from mouse brain lysates by CIN85 SH3 domains in glutathione S-transferase pull-down experiments. A direct interaction of synaptojanin 1 and PAK2 with CIN85 SH3 domains was confirmed by Far Western blotting.